| Sarah Weatherford, APRN | |
|
304 N 6th St, West Memphis, AR 72301-3221 | |
| (870) 732-1878 | |
| (870) 702-7111 |
| Full Name | Sarah Weatherford |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 5 Years |
| Location | 304 N 6th St, West Memphis, Arkansas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255987699 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 121731 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Reding And Leach Md Pllc | 7012258627 | 30 |
News Archive
The technique, described in the current issue of Molecular Therapy, could eventually lead to a method to correct genetic conditions in humans that cause diaphragm weakness and respiratory failure - a leading cause of death in tens of thousands of patients with forms of muscular dystrophy, including Pompe's disease. Thousands of Americans with muscle-weakening diseases are placed on ventilators each year, according to the Muscular Dystrophy Association.
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs.
In an EU project covering 11 countries, headed by Lund University in Sweden, it was calculated that some 1,000 cases would be found over an initial 1½-year period. Fully 5,000 were identified.
On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
› Verified 2 days ago
| Entity Name | Life Strategies Of Arkansas Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700950011 PECOS PAC ID: 1658360995 Enrollment ID: O20040511000740 |
News Archive
The technique, described in the current issue of Molecular Therapy, could eventually lead to a method to correct genetic conditions in humans that cause diaphragm weakness and respiratory failure - a leading cause of death in tens of thousands of patients with forms of muscular dystrophy, including Pompe's disease. Thousands of Americans with muscle-weakening diseases are placed on ventilators each year, according to the Muscular Dystrophy Association.
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs.
In an EU project covering 11 countries, headed by Lund University in Sweden, it was calculated that some 1,000 cases would be found over an initial 1½-year period. Fully 5,000 were identified.
On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
› Verified 2 days ago
| Entity Name | Reding & Leach Md Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245723584 PECOS PAC ID: 7012258627 Enrollment ID: O20190409001382 |
News Archive
The technique, described in the current issue of Molecular Therapy, could eventually lead to a method to correct genetic conditions in humans that cause diaphragm weakness and respiratory failure - a leading cause of death in tens of thousands of patients with forms of muscular dystrophy, including Pompe's disease. Thousands of Americans with muscle-weakening diseases are placed on ventilators each year, according to the Muscular Dystrophy Association.
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs.
In an EU project covering 11 countries, headed by Lund University in Sweden, it was calculated that some 1,000 cases would be found over an initial 1½-year period. Fully 5,000 were identified.
On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Weatherford, APRN 304 N 6th St, West Memphis, AR 72301-3221 Ph: (870) 732-1878 | Sarah Weatherford, APRN 304 N 6th St, West Memphis, AR 72301-3221 Ph: (870) 732-1878 |
News Archive
The technique, described in the current issue of Molecular Therapy, could eventually lead to a method to correct genetic conditions in humans that cause diaphragm weakness and respiratory failure - a leading cause of death in tens of thousands of patients with forms of muscular dystrophy, including Pompe's disease. Thousands of Americans with muscle-weakening diseases are placed on ventilators each year, according to the Muscular Dystrophy Association.
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs.
In an EU project covering 11 countries, headed by Lund University in Sweden, it was calculated that some 1,000 cases would be found over an initial 1½-year period. Fully 5,000 were identified.
On Friday, March 18, the U.S. Food and Drug Administration approved Anthim (obiltoxaximab) injection to treat inhalational anthrax in combination with appropriate antibacterial drugs. Anthim is also approved to prevent inhalational anthrax when alternative therapies are not available or not appropriate.
› Verified 2 days ago
Angela Christine Jones, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 200 West Broadway, West Memphis, AR 72301 Phone: 870-394-7010 Fax: 870-394-7001 | |
Nykkia N Sellers, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 700 N Missouri St Ste 2, West Memphis, AR 72301 Phone: 870-551-4409 | |
Mr. Robert Larry Smith, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 260d Shoppingway Blvd, West Memphis, AR 72301 Phone: 901-303-5040 | |
Marlo S. Williams, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1028 N Missouri St Ste 6, West Memphis, AR 72301 Phone: 870-400-0263 Fax: 870-400-0293 | |
Nikita Coleman-smith, AGPCNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 N 7th St, West Memphis, AR 72301 Phone: 870-735-3842 | |
Celena Lanette Jones, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 900 N 7th St, West Memphis, AR 72301 Phone: 870-735-3842 Fax: 870-394-4872 | |
Ms. Kathleen M Maples, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 200 W Tyler Ave, West Memphis, AR 72301 Phone: 501-658-2718 Fax: 501-724-3305 |